New Horizon Health IPO: Aiming to Become Pioneer in Cancer Screening
New Horizon Health, the pioneer in China’s colorectal cancer screening market has filed for an IPO on the Hong Kong Stock Exchange and the company...
506 Views
New Horizon Health (诺辉健康) Pre-IPO: Comparison with Exact Sciences
We compare the company's product with the benchmark product, Exact Sciences' Cologuard. We think ColoClear is ahead of the Cologuard with...
447 Views
New Horizon Health IPO Initiation: Screening for Cancer
New Horizon will have a listing hearing for a $300 million HK IPO this week. We believe that New Horizon has the right ingredients to capitalise on...
473 Views
ECM Weekly (10 January 2021) - RLX Technology, Roiserv, Yidu Tech, and Placements
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
392 Views
New Horizon IPO: Leaning Positive
New Horizon Health is a cancer diagnostics company that plans to list on the HKEX. The company has innovative tests for CRC, gastric, and...
636 Views